Jeffrey Frankel
Download the ICS Branding Pack
Open Discussion Session 26 On Demand Overactive Bladder 388 Vibegron Shows Meaningful Changes in Clinical Endpoints in Patients with Overactive Bladder: Analyses From EMPOWUR
User
Scientific Committee Member